Scott Kirkner Email

Head Financial Planning and Analysis . Melinta Therapeutics

Current Roles

Employees:
200
Revenue:
$38.8M
About
Melinta Therapeutics, Inc. (MLNT) is the largest pure-play antibiotics company, dedicated to saving lives threatened by the global public health crisis of bacterial infections through the development and commercialization of novel antibiotics that provide new therapeutic solutions. Its four marketed products include Baxdela® (delafloxacin), Vabomere® (meropenem and vaborbactam), Orbactiv® (oritavancin), and Minocin® (minocycline) for Injection. This portfolio provides Melinta with the unique ability to provide providers and patients with a range of solutions that can meet the tremendous need for novel antibiotics treating serious infections. Visit www.melinta.com for more information.
Melinta Therapeutics Address
44 Whippany Road
null, null
Melinta Therapeutics Email

Past Companies

Melinta TherapeuticsHead of Financial Planning and Analysis
Baxter International Inc.Director of Program Management
Baxter HealthcarePlant Controller

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.